Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisionsā€

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • CommuniquĆ©s
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • FranƧais
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux prĆ©paratoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux PrĆ©paratoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux prĆ©paratoires to UP and UPC
      • National measures relating to the Unitary PatentĀ 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • CommuniquĆ©s
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • PĆ©ter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 0406/09 (Cationic cassia derivatives/LUBRIZOL) 17-11-2010
Facebook X Linkedin Email

T 0406/09 (Cationic cassia derivatives/LUBRIZOL) 17-11-2010

European Case Law Identifier
ECLI:EP:BA:2010:T040609.20101117
Date of decision
17 November 2010
Case number
T 0406/09
Petition for review of
-
Application number
04755546.1
IPC class
A61K 8/73
Language of proceedings
EN
Distribution
DISTRIBUTED TO BOARD CHAIRMEN (C)

Download and more information:

Decision in EN 48.98 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

Cationic cassia derivatives and applications therefor

Applicant name
Lubrizol Advanced Materials, Inc.
Opponent name
Glycomer GmbH
Board
3.3.10
Headnote
-
Relevant legal provisions
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 100(b)
European Patent Convention Art 100(c)
European Patent Convention Art 114(2)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
Keywords

Late filed documents and evidence - admissibility

Amendments (allowable)

Sufficiency of disclosure (yes)

Novelty (yes)

Inventive step (no) - improvement not shown - obvious alternatives

Catchword
-
Cited decisions
T 0020/81
T 1072/98
T 0681/00
T 0555/04
T 0760/05
Citing decisions
T 1817/15
T 0796/16
T 0934/18
T 0980/19
T 1166/19
T 1958/19

I. The Appellant (Opponent) lodged an appeal against the decision of the Opposition Division rejecting the opposition against European patent No. 1 658 044 pursuant to Article 101(2) EPC. Independent claim 1 of the patent as granted reads as follows:

"1. A personal care composition comprising a polygalactomannan having repeating units containing a D-mannosyl to D-galactosyl residue ratio of 5 to 1 wherein a portion of the hydrogen groups on the pendant hydroxy substituents on the mannosyl and galactosyl residues are substituted with a group represented by the formula:

- AR**(1)

wherein A is a substituted or unsubstituted alkylene group containing 1 to 6 carbon atoms, and R**(1) is a group independently selected from -N(R**(3))3**(+) X**(-), -S(R**(3))2**(+) X**(-), and -P(R**(3))3**(+) X**(-), wherein R**(3) independently represents substituted and unsubstituted C1 to C24 alkyl, substituted and unsubstituted benzyl and substituted and unsubstituted phenyl; and X is any suitable anion that balances the charge on the onium cation, and an ingredient selected from surfactants, non-surfactant suspending agents, emulsifiers, emollients, moisturizers, hair conditioning agents, hair fixatives, film-formers, skin protectants, binders, chelating agents, disinfectants, insecticides, fungicides, deodorants, pest repellants, odoriferous materials, antimicrobial agents, antifungal agents, antibiotics, antidandruff agents, abrasives, adhesives, absorbents, colorants, deodorants, antiperspirant agents, humectants, opacifying and pearlescing agents, antioxidants, preservatives, propellants, spreading agents, exfoliants, keratolytic agents, blood coagulants, vitamins, sunscreen agents, artificial tanning accelerators, ultraviolet light absorbers, pH adjusting agents, botanicals, hair colorants, oxidizing agents, reducing agents, skin bleaching agents, pigments, anti-inflammatory agents, topical anesthetics, fragrance and fragrance solubilizers, particulates, microabrasives, abrasives, and combinations thereof."

II. The notice of opposition filed by the Appellant cited inter alia document

(7) US-A-5 733 854.

III. The Opposition Division held that the subject-matter of the patent-in-suit did not extend beyond the content of the application as filed (Article 100(c) EPC). In particular, granted claim 1 was supported by the combination of original claims 1 and 8. As there was no evidence that the skilled man could not manufacture the claimed compositions, the patent-in-suit disclosed the invention in a manner sufficiently clear and complete for it to be carried out by a skilled person (Article 100(b) EPC). The claimed subject-matter was novel since none of the cited documents disclosed a personal care composition comprising a cationic polygalactomannan derivative and a further cosmetic auxiliary as required by claim 1. In particular document (7) only disclosed polygalactomannan isolated from guar and locust bean having a mannose:galactose ratio of 2:1 and 4:1 respectively, whereas claim 1 of the patent-in-suit required a ratio of 5:1. The objective technical problem to be solved starting from the closest prior art document (7) was the provision of a personal care composition achieving better wet and dry detangling properties, in particular less polymer build up on the hair. The Respondent's test report filed on 4 June 2008 showed that the claimed compositions were solutions to this technical problem. Since there was no teaching in the available prior art that derivatized cassia, i.e. polygalactomannans with a 5:1 mannose:galactose ratio, would enhance or promote the wet and dry detangling properties of shampoo compositions or enhance the delivery and deposition of hair conditioning aids in shampoo, the subject-matter of claim 1 as granted involved an inventive step (Article 56 EPC).

IV. At the oral proceedings before the Board, held on 17 November 2010, the Respondent withdrew its auxiliary request 2. It further withdrew its conditional request for remittal to the department of the first instance should the Board of Appeal admit new documents (28) to (32) in the appeal proceedings. It defended the maintenance of the patent in suit as granted and on the basis of auxiliary request 1 whose set of claims differed from the granted only by the deletion of dependent claim 8, i.e. claim 1 of auxiliary request 1 being strictly identical to the granted claim 1 of the maim request. During these oral proceedings the Appellant argued for the first time in these appeal/opposition proceedings that the subject-matter of claim 1 lacked novelty with respect to document (24)

(24) FR-A- 2 773 990.

V. According to the Appellant, there was no basis in the application as filed for the composition of granted claim 1 which resulted from an inadmissible combination of restricted polygalactomannans with restricted further ingredients. The invention was insufficiently disclosed since the patent-in-suit failed to disclose any method for reliably determining the mannose:galactose ratio of polygalactomannans. The ratio mannose:galactose depended on the process of extraction and on the measuring method. Furthermore, the addition of polygalactomannans having high degrees of substitution in shampoos comprising surfactants would cause a precipitate thereby inhibiting any conditioning effect. The subject-matter of claim 1 lacked novelty with respect to document (7), since the disclosure of this document was not limited to guar polygalactomannan, but encompassed polygalactomannan obtained from any endosperm of leguminous seeds, in particular locust bean. A mannose:galactose ratio of 5.1:1 was found in locust bean gum. In support to its arguments the Appellant filed documents (28) to (33)

(28) US-A-6 063 402

(29) Canadian Journal of Chemistry, vol. 47,

pages 2883 to 2887, 1969,

(30) Industrial and Engineering Chemistry, vol. 41, pages 2887 to 2890,

(31) Carbohydrate Research, vol. 71, 1979, pages 205 to 230,

(32) Advances in Carbohydrate Chemistry and Biochemistry, Volume 31, Pages 241 to 312, 1975.

The problem to be solved with respect to document (7) which represented the closest prior art consisted merely in providing alternative personal care compositions since it was not shown that the choice of a polygalactomannan with a 5:1 mannose:galactose ratio resulted in any improvement over the prior art. In support of its position it filed experimental data (document (36)). In addition the comparative test reports provided by the Respondent were not fair, since the compared polygalactomannans differed not only by their ratio mannose:galactose, but also by a different average molecular weight and/or a different degree of cationic substitution, those further structural differences having an impact on the hair conditioning. Furthermore the test report filed on 10 October 2010 being late-filed should not be admitted into the appeal proceedings. It would have been a routine variation for a skilled person to choose a further known polygalactomannan useful in the cosmetic field, such as one having a mannose:galactose ratio of 5:1 since no effect was achieved. Thus, the skilled person would have arrived at the subject-matter claimed without having to exercise any inventive skill.

VI. According to the Respondent, no new combinations were created by incorporation of the ingredients listed in claim 8 as originally filed, save water and solvents, into claim 1 since there was no requirement that all those listed ingredients must be present together. The invention was adequately described to enable a skilled person to reproduce the subject-matter of claim 1. Standard methodologies for determining the ratio residues present in polysaccharide were known, furthermore cassia galactomannans having a mannose to galactose ratio of 5:1 were commercially available. The objection re undesirable interactions of highly substituted cationic derivatives was unfounded, moreover claim 1 was a product-claim without any reference to an effect to be achieved. Documents (28) to (33) were late filed as they were filed after the expiry of the nine month period for filing an opposition. These documents being not relevant should not be admitted into the proceedings. Nor should document (24) be admitted into the proceedings, this late filed document having already not been admitted by the Opposition Division for lack of relevance. The subject-matter of claim 1 was novel with respect to document (7), since this document did not disclose any polygalactomannan having a mannose:galactose ratio of 5:1. The technical problem to be solved in the light of document (7) which represented the closest prior art was to provide a composition having an improved hair conditioning effect. The claimed compositions characterized by polygalactomannans having a mannose:galactose ratio of 5 : 1 were solutions to this technical problem. In support to its arguments the Respondent relied on the test reports filed with the letters of 4 June 2008, 4 March 2010 (Document (39)) and 15 October 2010. The compositions comprising cationic cassia were according to the invention, since polygalactomannan obtained from cassia has a mannose:galactose ratio of 5:1, whereas those comprising cationic guar having a mannose:galactose ratio of 2:1 reflected the state of the art. It was not possible to carry out a comparison with polygalactomannans having exactly the same average molecular weight, since polygalactomannans were biological materials obtained from natural sources. Nevertheless the average molecular weights of the compared polygalactomannans were similar. In the test report filed with the letter of 4 June 2008, a composition according to the invention comprising derivatized cassia was compared to that comprising a derivatized guar to show the enhancement effect on the wet and dry combability of human hair tresses. The cationic guar used for the comparison was optimized with respect to its degree of cationic substitution to be better than the cationic guar of the state of the art. Accordingly, since the claimed polygalactomannan was shown to be better than the optimized cationic guar used in the comparison, it would inevitably be better than the structurally closest cationic guar of the prior art. The comparative test report described in document (39) was conducted by an independent and disinterested third Party and demonstrated the beneficial effect for cationic cassia at high levels of substitution. The delay of filing the test report of 15 October 2010 was caused by a lack of the Respondent's laboratory capacity. This test report compared compositions comprising cationic cassia and guar at the same level of cationic substitution. Even if the technical problem were only the provision of an alternative cosmetic composition, the skilled person would have had no reason to choose specifically galactomannan having a ratio of 5:1, all the more because document (7) indicated that guar gum was the preferred starting material.

VII. The Appellant requested that the decision under appeal be set aside and that the patent be revoked.

The Respondent requested that the appeal be dismissed or, subsidiarily, that the decision under appeal be set aside and the patent be maintained on the basis of auxiliary request 1 filed with the letter of 4 March 2010.

VIII. At the end of the oral proceedings the decision of the Board was announced.

1. The appeal is admissible.

2. Late filed evidences (Article 114(2) EPC)

2.1 Documents (28) to (33)

2.1.1 Documents (28) to (33) are new evidence cited for the first time in the Appellant's Statement of the Grounds of Appeal. The Respondent objected to admitting these documents into the proceedings for the reason that they were late-filed non-relevant documents.

2.1.2 According to Article 12(4) RPBA, the Board shall take into account all facts, evidence and requests submitted by the parties with the Statement of the Grounds of Appeal and the reply to it but may hold inadmissible facts, evidence and requests which could have been presented during the first instance proceedings.

2.1.3 The submission by an Appellant of new documents in the Statement of the Grounds of Appeal is to be considered as a normal action of a losing party (see decision T 1072/98, point 2.3 of the reasons, not published in OJ EPO). The Appellant who had lost the opposition proceedings should be given the opportunity to fill the gaps in its arguments by presenting further evidence in the second instance. These new documents are concerned with the content of mannose and galactose in naturally occurring polygalactomannans. The filing of these documents was prompted by the decision of the Opposition Division to acknowledge novelty with respect to document (7) on account of the mannose:galactose ratio of the polygalactomannan in the claimed compositions. Having regard to the present factual situation, the Appellant was entitled to file those new documents with the Statement of the Grounds of Appeal in order to show that the claimed mannose:galactose ratio could not render the subject-matter of claim 1 novel over document (7).

Thus, in the present case, documents (28) to (32) filed with the Statement of the Grounds of Appeal are not filed late in the sense of Article 114(2) EPC. Hence, these documents are to be taken into consideration in these appeal proceedings.

2.2 Document (24)

During the oral proceedings before the Board and for the first time during the opposition/appeal proceedings the appellant requested to consider document (24) for lack of novelty. The Appellant argued that after thorough rereading of this document it thought that it was novelty-destroying for claim 1. The relevance of this document was, however, again disputed by the Respondent which requested not to admit it into the appeal proceedings.

Document (24) was filed before the first instance on 24 October 2008, i.e. after the expiry of the opposition period, and the opposition division decided to not admit it into the proceedings for lack of relevance. Furthermore, this document had never been referred to in the appeal proceedings until during the oral proceedings before the Board.

Under these circumstances, the Board therefore exercises its discretionary power conferred by Article 114(2) EPC to disregard this document.

2.3 Respondent's new experimental report

2.3.1 The new comparative test report was submitted by the Respondent on 15 October 2010, i.e. more than 6 months after the filing of its reply to the Statement of the Grounds of Appeal and about one month before the oral proceedings before the Board. It is late-filed. The Appellant contested the admissibility of this new evidence in the proceedings in view of its belatedness.

2.3.2 According to Article 114 (2) EPC the EPO may disregard facts or evidence which are not submitted in due time by the Parties concerned. Thus, any amendment to a party's case after it has filed its grounds of appeal or reply may be admitted and considered at the Board's discretion. The discretion shall be exercised in view of inter alia the complexity of the new subject matter submitted, the current state of the proceedings and the need for procedural economy (Article 13 (1) RPBA). More particularly, amendments sought to be made after oral proceedings have been arranged shall not be admitted if they raise issues which the Board or the other party cannot reasonably be expected to deal with without adjournment of the oral proceedings (Article 13(3) RPBA).

According to the established jurisprudence of the Boards of appeal the relevance of the late-filed evidence is a crucial criterion for deciding on their admissibility in the proceedings, however, other criteria are important, such as how late, whether the late submission of evidence constitutes an abuse of proceedings, or if their admission excessively delays the proceedings (see T 760/05, point 1 of the reasons, T 681/00, point 2 of the reasons; T 555/04, point 1 of the reasons). Thus, the Boards of Appeal making use of their discretion under Article 114 (2) EPC in order to ensure fair and prompt proceedings are entitled to refuse to take them into account.

2.3.3 According to the Respondent, this late filed experimental report was filed to show that the claimed compositions compared to those of document (7) improve the conditioning of hair. However, the comparison of the compositions performed in these tests does not show the effect of the sole distinguishing characteristic and therefore does not demonstrate an improvement in hair conditioning by the claimed compositions when compared to those of document (7) (see point 6.4.3 below). Thus, these comparative tests do not seem to be pertinent for the issue of inventive step.

2.3.4 Moreover if the Respondent, in the light of the Statement of the Grounds of Appeal, was of the opinion that the evidences already on file were insufficient to support its position, it would have had to submit any new evidence, at the latest, with its reply to the Statement of the Grounds of Appeal. At the same time it would have to submit arguments as to why the Appellant reason's were not suitable for challenging the recognition of inventive step by the Opposition Division, especially in view of the Appellant's new evidence. In the present case, the sole reason given by the Respondent to justify the late filing of this experimental report was a lack of capacity of the laboratory. However, the Board does not accept this justification for the following reasons:

With letter of 22 December 2009, the Respondent requested a second two-month extension of the time limit set for replying to the Appellant's statement of ground of appeal which comprised experimental evidences, i.e. inter alia document (36) dealing with a combing test. The Respondent justified its request by its wish to file a complete response and that due to a lack of laboratory capacity more time was needed to evaluate and verify the Appellant's experiments. This reply came with the letter of 4 March 2010, where the Respondent commented on the Appellant's experimental evidence document (36) and provided a new experimental report (document (39)). That appeared to be the complete reply to the Appellant's grounds of appeal, since the Respondent had never announced that it intended to file more comparative data or that further experiments were ongoing. Hence, the reason of lack of laboratory capacity given for justifying the filing of a comparative test report one month before the oral proceedings does not persuade the Board to accept this late-filed evidence. Moreover the introduction of an experimental report in the proceedings at this stage without adjourning the oral proceedings would be contrary to the principle of equal treatment of the parties and would adversely affect the Appellant.

2.3.5 Thus, the late-filed test report of 15 October 2010, which in addition lacks relevance for the decision to be taken, is not admitted into the proceedings (Article 114(2) EPC).

Main request

3. Amendments (Article 100(c) EPC)

Claim 1 is based on the combination of claim 1 as originally filed with claim 8 dependent thereon.

Additionally the radical R**(1) of the substituent of the galactomannan of claim 1 as granted is restricted to the definitions -N(R**(3))3**(+) X**(-), -S(R**(3))2**(+) X**(-), and -P(R**(3))3**(+) X**(-) by the mere deletion of the other definitions present in claim 1 as originally filed and the second component of the composition of claim 1 as granted are the ingredients listed in original claim 8 without water and solvents.

The restriction of the lists of alternative definitions disclosed in the application as filed is not objectionable as this limitation does not result in singling out a particular combination of specific definitions, i.e. a hitherto not specifically mentioned sub-class of components. It maintains the remaining subject-matter of claim 1 as generic lists of alternative definitions differing from the original lists only by their smaller size.

Accordingly, the combination of original claims 1 and 8 forms a proper basis for claim 1 as granted. For this reason, the Board concludes that the subject-matter of claim 1 does not extend beyond the content of the application as filed such that the requirements of Article 123(2) EPC are satisfied and the ground for opposition pursuant to Article 100(c) EPC is disqualified.

4. Insufficiency of disclosure (Article 100(b) EPC)

The Appellant claimed that the measuring method of the mannose:galactose ratio was flawed since the patent did not specify according to which method and how the skilled person should perform the measurement of this ratio. It was the Appellant's point that, owing to this insufficient information with respect to this critical characteristic of polygalactomannans, the skilled person could not assess whether a composition falls within or outside the scope of claim 1.

With respect to sufficiency of disclosure, the relevant question is whether the patent in suit provides sufficient information which enables the skilled person when taking into account common general technical knowledge to reproduce the claimed compositions. The Appellant has however conceded that the skilled person was able to prepare polygalactomannans with the claimed mannose:galactose ratio. The Appellant's objection rather refers to determining the limits of the subject-matter claimed. Accordingly, that objection is thus related to the question whether the claims clearly define the matter for which protection is sought, which is a matter of Article 84 EPC. The Board observes that Article 84 EPC is not a ground for opposition within the sense of Article 100 EPC, so that this Appellant's objection cannot be taken into consideration.

The second Appellant's objection concerns an alleged absence of conditioning effect of compositions comprising polygalactomannans having high degrees of cationic substitutions. However, the conditioning effect achieved by the claimed composition is an issue relating to the technical problem solved by the invention to be considered when assessing inventive step. Thus, it is not relevant for sufficiency of disclosure, as claim 1 only requires structural characteristics relating to the composition without specifying any effect to be achieved. Thus, the Appellant's second objection must also be rejected.

Consequently, the Appellant's challenge to the sufficiency of the disclosure of the patent in suit under Article 100(b) EPC fails.

5. Novelty (Article 54 EPC)

5.1.1 Document (7) discloses a detergent composition useful inter alia for cleaning and/or conditioning human hair comprising a cationically derivatized polygalactomannan wherein the cationic substituants are of the formula R1R2R3R4N**(+) X**(-) wherein R1 is a monohydroxylated or polyhydroxylated alkyl group containing between one and about six carbon atoms; R2 and R3 are independently, alkyl groups containing between one and six carbon atoms; R4 is an alkyl group containing between one and 24 carbon atoms; and X is a halide (see claims 1 and 8). The detergent composition typically include one or more surfactants (see column 8, lines 36 and 37). Document (1) furthermore indicates that polygalactomannans are polysaccharides composed principally of galactose and mannose units and are usually found in the endosperm of leguminous seeds, such as guar, locust bean, honey locust, flame tree, and the like, guar and locust bean gum being the preferred sources of the polygalactomannans and that the ratio of galactose to mannose in the guar polymer being 1:2 and in the locust bean gum 1:4 (see column 4, lines 35 to 39 and 44 to 49).

5.1.2 The Parties had divergent views on the issue of whether or not document (7) disclosed a polygalactomannan having a mannose:galactose ratio of 5:1. Although according to document (7) polygalactomannans from locust bean have a mannose:galactose ratio of 4:1, the Appellant relied on other documents, in particular documents (32) and (33), to support its allegation that the disclosure of locust bean gum in document (7) actually is equal to a disclosure of polygalactomannans having a mannose:galactose ratio of 5:1.

Regardless of whether or not a mannose:galactose ratio of 5:1 for polygalactomannans obtained from locust bean is disclosed in documents (32) or (33), the Board notes that according to the established jurisprudence a document does not disclose a specific technical feature if it does not emerge clearly and unambiguously therefrom. Although polygalactomannans found in the endosperm of leguminous seeds encompass polygalactomannans having the claimed mannose:galactose ratio of 5:1, document (7) does not disclose clearly and unambiguously that ratio, with the consequence that the Board concurs with the finding of the decision under appeal in relation to the absence of any disclosure of that particular ratio in document (7).

6. Inventive step (Article 56 EPC)

According to the established jurisprudence of the Boards of Appeal it is necessary, in order to assess inventive step, to establish the closest state of the art, to determine in the light thereof the technical problem which the invention addresses and successfully solves, and to examine the obviousness of the claimed solution to this problem in view of the state of the art. This "problem-solution approach" ensures that inventive step is assessed on an objective basis and avoids an ex post facto analysis.

6.1 Closest prior art

Document (7) discloses a composition comprising a cationically derivatized polygalactomannan and surfactants (see point 5 above). The Board considers, in agreement with the Opposition Division and the Parties, that document (7) represents the closest state of the art, and, hence, takes it as the starting point in the assessment of inventive step.

6.2 Technical problem underlying the patent in suit

In view of document (7), the Respondent submitted that the technical problem underlying the patent in suit consisted in providing a composition having an improved hair conditioning effect.

6.3 Solution

The proposed solution to this problem is the polygalactomannan-containing composition according to claim 1 characterized in that the polygalactomannan has a mannose:galactose ratio of 5 : 1.

6.4 Success

6.4.1 In order to demonstrate that the technical problem as defined above has effectively been solved by the claimed compositions, the Respondent relied on the results of the comparison of the experimental reports filed with the letters of 4 June 2008 and 4 March 2010 (document (39)) and on the belated report filed on 15 October 2010. In these reports shampoo compositions comprising hydroxypropyltrimonium chloride-substituted polygalactomannan and differing from each other only by the structure of the polygalactomannan were compared for their conditioning effects on hair in wet and dry combing tests.

6.4.2 In the Experimental report filed with the letter of 4 June 2008, a composition comprising a polygalactomannan obtained by substituting cassia galactomannan with hydroxypropyltrimonium chloride to a degree of cationic substitution of 0.91 is compared with a composition comprising the commercial product JaguarĀ® C13S which is a substituted guar galactomannan having a degree of cationic substitution of 0.19 (see example 1 on page 14 and 15 of the letter dated 4 June 2008).

In the experimental report filed with the letter of 4 March 2010 (document (39)), a composition comprising a commercial cassia hydroxypropyltrimonium chloride galactomannan having an average molecular weight (MW) of 600000 and a degree of cationic substitution corresponding to a charge density of 3.0 mEq/g is compared with a composition comprising a commercial guar hydroxypropyltrimonium chloride galactomannan having an average molecular weight (MW) of 1200000 and a degree of cationic substitution corresponding to a charge density of 0.7 mEq/g (see page 638, last paragraph).

In the belatedly-filed experimental report filed with the letter of 15 October 2010 compositions comprising cationic cassia are compared with compositions comprising cationic guar having similar cationic charge density or degree of cationic substitution.

According to the Respondent's uncontested submission the compositions comprising cationic cassia are according to the invention, since polygalactomannan obtained from cassia has a mannose:galactose ratio of 5:1, whereas those comprising cationic guar having a mannose:galactose ratio of 2:1, represent the closest prior art (see patent-in-suit, sentence bridging pages 2 and 3; document (7), column 4, lines 44 and 45).

However, since the polygalactomannans of the compared compositions are obtained from cassia and guar respectively, they differ one from the other not only by their mannose:galactose ratio, which is the characterizing feature of the invention, but also by their average molecular weight.

The Respondent had not contested the existence of this further structural difference between the compared polygalactomannans, but argued that it was not possible to carry out a comparison with polygalactomannans having exactly the same average molecular weight, since polygalactomannans are material which are obtained from biological sources, and that the average molecular weights of the compared polygalactomannans were anyway similar.

However the Respondent's submission that the average molecular weight of polygalactomannan obtained from cassia are similar to that obtained from guar does not seem to be supported by the facts, since the Respondent's experimental report of 4 March 2010 indicates that the average molecular weight of the compared polygalactomannans shows substantial molecular weight differences (600000 versus 12000000). Accordingly, in the absence of any substantiating facts and corroborating evidence, the Board considers this submission as a mere speculation, that the Board does not agree with.

6.4.3 According to established jurisprudence of the Boards of appeal, in the case where comparative tests are chosen to demonstrate an inventive step with an improved effect over a claimed area, the nature of the comparison with the closest state of the art must be such that the effect is convincingly shown to have its origin in the distinguishing feature of the invention, i.e., in the present case, in the mannose:galactose ratio of the polygalactomannans of the claimed compositions.

Since, as submitted by the Appellant and confirmed by the Respondent's comparative test report, document (39), page 641, fourth paragraph, the molecular weight of the polygalactomannan is susceptible to have an impact on the conditioning of the hair, none of the Respondent's comparative test reports comparing polygalactomannans with different molecular weights can truly reflect the impact of the essential technical feature distinguishing the claimed composition from the closest prior art, namely the mannose:galactose ratio of 5:1 of the polygalactomannan. Hence, they do not properly demonstrate that the purported improvement of the claimed composition is necessarily due to the mannose:galactose ratio of 5:1 of the polygalactomannan comprised in the claimed compositions.

The failure of this belatedly filed test report to show a causal link between the characterising feature of the claim and the purported improvement is therefore a ground for not admitting it into the Appeal proceedings (see point 2.3 above).

6.4.4 In addition to the differences concerning the molecular weight and the mannose:galactose ratio, the polygalactomannans compared in the test reports filed on 4 June 2008 and 4 March 2010 further differ in their degree of cationic substitution, i.e. in their charge density. However, as submitted by the Appellant and confirmed by the Respondent's comparative test report of document (39), page 641, fourth paragraph, the charge density also has an impact on the hair conditioning. Consequently, these test reports cannot show that the alleged improved hair conditioning has its origin in the distinguishing feature of the invention, namely the ratio mannose:galactose of 5:1 of the polygalactomannan, with the consequence that the comparisons and these test reports cannot support the alleged effect.

6.4.5 The Respondent alleged that the cationic guar used for the comparison was better than any other cationic guar of the prior art, however, without providing any comparative data in support of its argumentation. Hence, in the absence of any substantiating facts and corroborating evidence, the Board does not consider the Appellant's allegation to be correct.

6.4.6 As the test reports which according to the Respondent show the purported improvement are not based on fair comparisons, it is not necessary to evaluate their results. Furthermore, since the Respondent's test reports fail to show that the problem of improving hair conditioning is solved by the claimed compositions, it is unnecessary to address the Appellant's counter test report document (36).

6.4.7 Since the Respondent did not present a proper comparison between the closest prior art and the claimed invention, the purported technical effect on the conditioning of the hair is not supported by evidence.

According to the jurisprudence of the Boards of Appeal, alleged but unsupported effects cannot be taken into consideration for the determination of the problem underlying the claimed invention (see e.g. decision T 20/81, OJ EPO 1982, 217, point 3, last paragraph of the reasons).

6.4.8 Since in the present case the alleged effect, i.e. improvement of hair conditioning, lacks the required experimental support, the technical problem as defined above (see point 6.4.4) needs to be redefined in a less ambitious way, and in view of the teaching of document (7) can be seen as providing alternative cosmetic compositions.

6.5 Obviousness

Finally, it remains to be decided whether or not the proposed solution to this objective technical problem (see point 6.4.8 above) is obvious in view of the cited state of the art, namely whether the composition according to claim 1 of the patent in suit, is an obvious alternative composition in view of the state of the art.

6.5.1 The polygalactomannans of the cosmetic compositions disclosed in document (7) are polysaccharides composed principally of galactose and mannose units found in the endosperm of leguminous seeds, such as guar, locust bean, honest locust, flame tree. (see column 4, lines 35 to 39). Thus any polygalactomannans so covered, including therefore the polygalactomannans as specified in claim 1, are taught to be suitable for the preparation of the cosmetic compositions according to document (7).

The choice of particular polygalactomannans within the ambit envisaged by the general teaching of document (7), i.e, those having a ratio mannose:galactose of 5:1 as required in claim 1, is therefore neither critical nor purposive for solving the objective problem underlying the patent in suit, but is an arbitrary restriction of no technical significance. Thus, this choice can be seen as lying within the routine activity of the skilled person faced with the objective problem of providing alternative compositions and thus does not involve an inventive step.

6.5.2 For these reasons, the subject-matter of claim 1 is obvious in the light of document (7).

6.5.3 The Respondent argued in support of inventive step that document (7) did not prompt the skilled person to select the polygalactomannans as specified in claim 1 of the patent in suit since document (7) only suggests polygalactomannans obtained from guar, locust bean, honest locust, flame tree, i.e. which are outside of the scope of present claim 1.

However, when seeking to provide mere alternative compositions, the skilled person does not restrict the teaching of document (7) to its preferred embodiments, but takes into consideration all features taught in that document, among them, using any polygalactomannan found in endosperm of leguminous seeds including cassia.

6.6 As a result, the Respondent's main request is not allowable for lack of inventive step pursuant to Article 56 EPC.

Auxiliary request 1

7. Claim 1 of auxiliary request 1 is identical to claim 1 of the main request, thus, the subject-matter of claim 1 of auxiliary request 1 is obvious and does not involve an inventive step.

Consequently, auxiliary request 1 is rejected for lack of inventive step.

Order

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility